All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)- 14:26, 20 September 2023 User account Mahitha Reddy talk contribs was created
- 10:31, 20 September 2023 User account Sunilkumar123 talk contribs was created
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anti-dabigatran antibody fragments (Created page with "Category:Anticoagulant reversal agents")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anticoagulant reversal agents (Created page with "Category:Classical hematology medications")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Heparin antagonist (Created page with "Category:Anticoagulant reversal agents")
- 23:30, 18 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 23:28, 18 September 2023 Jwarner talk contribs created page Category:Folic acid analog (Created page with "Category:Potentiating agents Category:Chemotherapy protective agents")
- 23:27, 18 September 2023 Jwarner talk contribs created page Category:Potentiating agents (Created page with "A category of drugs that potentiate the effect of another drug or localized intervention. Category:Drugs")
- 13:43, 18 September 2023 User account Themedicator's talk contribs was created
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:Anti-CD7 CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:T-cell acute lymphoblastic leukemia medications (investigational) (Created page with "Category:T-cell acute lymphoblastic leukemia medications")
- 15:19, 15 September 2023 Jwarner talk contribs created page BE-CAR7 (Created page with "==Mechanism of action== Base-edited ("off the shelf") CAR T-cells directed against CD7 ==Preliminary data== #Chiesa R, Georgiadis C, Syed F, Zhan H, Etuk A, Gkazi SA, Preece...")
- 14:55, 15 September 2023 Jwarner talk contribs created page Category:Cereblon E3 ubiquitin ligase modulators (Created page with "Category:Enzyme inhibitors")
- 14:54, 15 September 2023 Jwarner talk contribs created page Mezigdomide (BMS-986348) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezigdomide NCI Drug Dictionary]: A modulator of the E3 ubiquitin ligase com...")
- 06:51, 15 September 2023 User account Kuusoft talk contribs was created
- 16:44, 13 September 2023 Jwarner talk contribs created page Category:Topoisomerase I inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 16:41, 13 September 2023 Jwarner talk contribs created page Category:Alkyl sulfonates (Created page with "Category:Alkylating agents")
- 19:47, 12 September 2023 User account Kbml100 talk contribs was created
- 19:23, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (investigational) (Created page with "Category:Urothelial carcinoma medications")
- 13:44, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinomas (Created page with "Category:Genitourinary cancers")
- 12:35, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (Created page with "Medications which have been shown to have some degree of efficacy in the treatment of urothelial carcinoma. Category:Genitourinary oncology medications")
- 12:21, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma regimens (Created page with "Category:Genitourinary (GU) oncology regimens")
- 12:16, 9 September 2023 Jwarner talk contribs created page Urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:04, 9 September 2023 Jwarner talk contribs moved page Bladder cancer - historical to Urothelial carcinoma - historical
- 11:53, 9 September 2023 Jwarner talk contribs moved page Bladder cancer to Urothelial carcinoma
- 06:38, 8 September 2023 User account Cataliesw talk contribs was created
- 16:31, 7 September 2023 Jwarner talk contribs moved page Olverembatinib (HQP1351) to Olverembatinib (HQP-1351) (naming standardization)
- 01:25, 7 September 2023 Jwarner talk contribs created page How I Treat (Created page with "The "How I Treat" series has been published by ''Blood'' for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles ar...")
- 22:52, 6 September 2023 User account Carlobch talk contribs was created
- 19:32, 6 September 2023 User account Cyandell talk contribs was created
- 18:35, 6 September 2023 User account Elanglois talk contribs was created
- 20:59, 5 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma regimens (Created page with "Category:Gastrointestinal (GI) oncology regimens")
- 20:58, 5 September 2023 Jwarner talk contribs created page Small bowel adenocarcinoma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:09, 4 September 2023 Jwarner talk contribs moved page Eculizumab (Epysqli) to Eculizumab-epys (Epysqli) (Biosimilar naming convention)
- 12:08, 4 September 2023 Jwarner talk contribs moved page Eculizumab (Bekemv) to Eculizumab-beke (Bekemv) (Biosimilar naming convention)
- 12:02, 4 September 2023 Jwarner talk contribs created page Eculizumab (Bekemv) (Created page with "==General information== Class/mechanism: Complement inhibitor; monoclonal antibody that binds to complement protein C5, preventing its cleavage to C5a and C5b and the formatio...")
- 12:02, 4 September 2023 Jwarner talk contribs created page Eculizumab (Epysqli) (Created page with "==General information== Class/mechanism: Complement inhibitor; monoclonal antibody that binds to complement protein C5, preventing its cleavage to C5a and C5b and the formatio...")
- 20:11, 3 September 2023 Jwarner talk contribs created page Category:Anti-TFPI antibodies (Created page with "Category:Hematologic monoclonal antibodies")
- 20:11, 3 September 2023 Jwarner talk contribs created page Concizumab (Alhemo) (Created page with "Anti-TFPI antibody ==Supporting data== *'''explorer7:''' Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J,...")
- 11:15, 30 August 2023 Jwarner talk contribs created page Category:ACVR1 inhibitors (Created page with "A class of drugs that inhibit activin A receptor, type I (ACVR1). Category:Serine/threonine kinase inhibitors")
- 10:45, 30 August 2023 Jwarner talk contribs created page Category:Myelodysplastic syndrome medications (investigational) (Created page with "Category:Myelodysplastic syndrome medications")
- 23:31, 29 August 2023 Jwarner talk contribs created page Breast cancer, triple negative - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 18:47, 29 August 2023 Jwarner talk contribs created page Breast cancer, ER-positive - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 04:37, 29 August 2023 User account Barrybear12 talk contribs was created
- 00:32, 29 August 2023 Warner-admin talk contribs created page Category:Evidence-based oncology (Created page with "A collection of pages that discuss the evidence basis of inclusion on HemOnc.org, and additional considerations. This collection is managed by the Associate Editor of Evidence...")
- 12:19, 27 August 2023 Jwarner talk contribs created page Breast cancer, ER-positive - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 01:01, 27 August 2023 Jwarner talk contribs created page Breast cancer, HER2-positive - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 22:47, 25 August 2023 User account Anthony8n talk contribs was created
- 21:03, 24 August 2023 User account Hued talk contribs was created
- 11:29, 24 August 2023 Jwarner talk contribs created page Divarasib (GDC-6036) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/divarasib NCI Drug Dictionary]: An orally available inhibitor of the oncogen...")